Share price: 104.00p

Holding(s) in Company

10th February 2016

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
 ii
CELLO GROUP

 

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation:
 iii
Ennismore Fund Management Limited
4. Full name of shareholder(s) 
 (if different from 3.):iv
1) Ennismore European Smaller Companies Fund

2) Ennismore European Smaller Companies Master Hedge Fund

5. Date of the transaction and date on
which the threshold is crossed or
reached:
 v
8 February 2016
6. Date on which issuer notified: 10 February 2016
7. Threshold(s) that is/are crossed or
reached: 
vi, vii
Above 9%

 

 

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of  voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00B0310763 7,647,330 7,647,330 7,847,330 7,847,330 9.2%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date 
xiii
Exercise/
Conversion Period 
xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price Expiration datexvii Exercise/
Conversion period 
xviii
Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
7,847,330 9.2%
Note: Annex should only be submitted to the FCA not the issuer

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150